Published in Exp Brain Res on January 01, 1988
Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A (2004) 3.45
Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells (2007) 2.22
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. Eur J Neurosci (2006) 1.32
The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors. Neurobiol Dis (2008) 0.95
Stem cells in regenerative medicine. Laser Ther (2013) 0.88
Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats. J Comp Neurol (2009) 0.87
Treating Parkinson's disease in the 21st century: can stem cell transplantation compete? J Comp Neurol (2014) 0.86
Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells. Proc Natl Acad Sci U S A (1989) 0.86
alpha-Synuclein: a therapeutic target for Parkinson's disease? Pharmacol Res (2008) 0.82
Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease. Exp Neurol (2016) 0.78
Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration. Neurobiol Dis (2015) 0.78
Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease. Stem Cell Rev (2016) 0.76
Repairing the Aged Parkinsonian Striatum: Lessons from the Lab and Clinic. J Clin Cell Immunol (2016) 0.75
Embryonic and mature astrocytes exert different effects on neuronal growth in rat ventral mesencephalic slice cultures. Springerplus (2015) 0.75
Replacing Dopamine Neurons in Parkinson's Disease: How did it happen? J Parkinsons Dis (2017) 0.75
Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science (1997) 3.40
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci (1999) 3.06
Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience (2008) 2.84
Cell replacement therapies for central nervous system disorders. Nat Neurosci (2000) 2.84
Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry (2000) 2.48
Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature (1987) 2.33
Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol (1998) 2.20
Learning deficit in BDNF mutant mice. Eur J Neurosci (1997) 2.20
Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci U S A (1997) 2.16
Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci (1999) 2.15
L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci (1998) 2.10
Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature (1999) 2.07
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med (1992) 2.01
Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience (2000) 1.95
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci (1995) 1.90
Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron (1991) 1.74
Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res (1979) 1.68
Weight loss in Huntington disease increases with higher CAG repeat number. Neurology (2008) 1.66
Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat Med (1995) 1.61
Spatial learning and motor deficits in aged rats. Neurobiol Aging (1984) 1.60
The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol Scand Suppl (1974) 1.56
Mesencephalic dopamine neurons projecting to neocortex. Brain Res (1974) 1.54
High-fat diet impairs hippocampal neurogenesis in male rats. Eur J Neurol (2006) 1.53
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol (1994) 1.50
Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat. Neuroscience (1985) 1.44
Functional integration of cortical grafts placed in brain infarcts of rats. Ann Neurol (1993) 1.43
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons. Neurobiol Dis (2011) 1.43
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet (2001) 1.42
N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke. Eur J Neurosci (2001) 1.39
Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res (1975) 1.39
Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species. Neuroscience (2002) 1.38
The glyoxylic acid fluorescence histochemical method: a detailed account of the methodology for the visualization of central catecholamine neurons. Histochemistry (1974) 1.38
Cell therapy in Parkinson's disease - stop or go? Nat Rev Neurosci (2001) 1.34
Dopamine-containing neurons in the spinal cord: anatomy and some functional aspects. Ann Neurol (1983) 1.34
Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development (2006) 1.33
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol (2000) 1.30
Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc Natl Acad Sci U S A (1999) 1.30
Suppressed epileptogenesis in BDNF mutant mice. Exp Neurol (1995) 1.30
5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J Neurochem (1975) 1.29
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol (1997) 1.29
The production of catecholamine-containing cells in vitro by young chick embryos: effects of "nerve growth factor" (NGF) and its antiserum. Neurobiology (1973) 1.28
Sleep fragmentation elevates behavioral, electrographic and neurochemical measures of sleepiness. Neuroscience (2007) 1.27
A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death Differ (2011) 1.27
Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci U S A (1995) 1.26
The organization of tubero-hypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain. Brain Res (1973) 1.25
Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature (1990) 1.24
Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain (2000) 1.24
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp Brain Res (1988) 1.23
Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage. Exp Neurol (1995) 1.22
Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. Neuroscience (2005) 1.22
Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res (1980) 1.21
Organization of catecholamine neurons projecting to the frontal cortex in the rat. Brain Res (1978) 1.21
Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol Scand Suppl (1973) 1.21
Caspase inhibitors increase short-term survival of progenitor-cell progeny in the adult rat dentate gyrus following status epilepticus. Eur J Neurosci (2001) 1.18
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain (2000) 1.18
Dopamine-containing cells in sympathetic ganglia. Acta Physiol Scand (1970) 1.18
Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol Aging (1992) 1.17
Behavioral state control through differential serotonergic inhibition in the mesopontine cholinergic nuclei: a simultaneous unit recording and microdialysis study. J Neurosci (1998) 1.16
Synaptic dysfunction in Huntington's disease: a new perspective. Cell Mol Life Sci (2005) 1.16
Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Eur J Neurosci (1999) 1.16
Regional incorporation and site-specific differentiation of striatal precursors transplanted to the embryonic forebrain ventricle. Neuron (1995) 1.15
A method for differentiating dopamine from noradrenaline in tissue sections by microspectrofluorometry. J Histochem Cytochem (1968) 1.15
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain (1999) 1.14
Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc Natl Acad Sci U S A (1993) 1.14
Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol (1992) 1.13
Increased production of the TrkB protein tyrosine kinase receptor after brain insults. Neuron (1993) 1.13
Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence. Neuroscience (1995) 1.12
Nerve growth factor: stimulation of regenerative growth of central noradrenergic neurons. Science (1972) 1.12
Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch Ital Biol (2001) 1.12
Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci (1997) 1.11
Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res (1986) 1.11
Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc Natl Acad Sci U S A (2001) 1.11